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Aim 
To explore people’s experiences of living with lymphoedema and to assess the impact of 
access to local lymphoedema clinics on their condition and thus their lives. 
Background  
A chronic condition caused by reduced lymphatic function, lymphoedema leads to swelling, 
pain, mobility problems and risk of infections and can adversely affect quality of life. 
Lymphoedema is of international concern as its prevalence is projected to rise. Yet awareness 
of lymphoedema is limited, diagnostic delay common and access to specialist treatment 
restricted. The concept of local lymphoedema clinics is gaining support and the All Wales 
Lymphoedema Service was founded in 2011. However empirical investigation of local 
lymphoedema services remains limited.  
Design  
A qualitative exploratory study consisting of focus group interviews in every Welsh 
lymphoedema clinic (n= 8).  
Methods  
A convenience sample of adults living with lymphoedema in Wales was recruited. Data were 
collected in digitally recorded focus groups during July and August 2013. Interviews were 
fully transcribed and analysed using a qualitative content approach. 
Findings:  
Fifty-nine people participated in eight focus groups. Three main themes emerged from the 
analysis: Living with lymphoedema is a battle; delays in obtaining a correct diagnosis and the 
positive impact of lymphoedema clinics on participants’ lives. Locally accessible clinics 
made meaningful differences to peoples’ lymphoedema, engendered positive patient-reported 
outcomes and improved engagement with and adherence to lymphoedema self-management.   
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Conclusions:  
Local specialist lymphoedema clinics can make a positive difference. They may be cost-
effective and further investigation, including economic evaluation is necessary.    
KEY WORDS  
LYMPHOEDEMA; FOCUS GROUPS; QUALITATIVE RESEARCH; SELF-
MANAGEMENT; SUPPORTIVE CARE; ADHERENCE; CHRONIC CONDITION;  
PRIMARY CARE CLINICS; NURSE; NURSING.   
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SUMMARY STATEMENT  
Why is this research needed? 
 As populations age the prevalence of lymphoedema, a progressive, enduring, disabling, 
frequently unrecognised condition with profound psychosocial and economic sequelae, 
is projected to increase.  
 Little is known about the acceptability and efficacy of local specialist multiprofessional 
lymphoedema clinics from the standpoint of people living with lymphoedema.  
What are the key findings? 
 Participants identified that across care settings, including oncology, practitioners’ had 
insufficient awareness and understanding about lymphoedema in terms of impact, 
prevention, diagnosis and management. 
 Participants’ reports indicated that access to local specialist lymphoedema clinics and 
continuity of patient-centred, holistic care conferred physical, psychosocial and 
economic benefits.  
 Although access to local specialist practitioners, including nurses, motivated many 
individuals to sustain their engagement in lymphoedema self-management some were 
unable to do this in the absence of on-going practical support.  
How should the findings be used to influence policy/practice/research/education? 
 Policy makers should consider the potential of local lymphoedema clinics to ensure 
best outcomes for patients and promote effective use of healthcare resources by 
sustaining patient engagement in lymphoedema self-management.  
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 Further research should be commissioned and conducted to provide evidence of the 
clinical and cost-effectiveness of locally accessible multiprofessional lymphoedema 
clinics.  
 Education providers should be aware that lymphoedema and its management has a 
place in pre-registration nurse education and for generalists and specialists in post-
registration curricula.      
  
5 
 
INTRODUCTION  
Lymphoedema is a chronic condition caused by reduced lymphatic function (Taghian et al. 
2014). It leads to swelling, pain, mobility problems, risk of infections and skin texture 
changes. Lymphoedema affects an estimated 140-250 million people worldwide (Greene et al. 
2015). Many more are at risk; particularly in developing countries where mosquito 
transmitted lymphatic filariasis is endemic (Person et al. 2009). In the developed world 
lymphoedema prevalence will rise due to growing obesity, chronic illnesses and cancer 
juxtaposed against increasing life expectancy (Christensen et al. 2009, Office for National 
Statistics 2015). This will place pressure on nursing and healthcare systems and generate 
concern for policymakers.  
Poor awareness and understanding amongst healthcare professionals and the public 
means lymphoedema is frequently unrecognised. People with non-cancer related 
lymphoedema remain relatively invisible, experiencing considerable diagnostic delay and 
difficulties accessing limited specialist services (Williams et al. 2004, Bogan et al. 2007, 
Sneddon 2008, Deng et al. 2015). Ultimately the care and support needs of many individuals 
may not be identified or appropriately and effectively met resulting in preventable 
complications and suffering (Sneddon 2008). This is because lymphoedema can be 
profoundly disabling, disfiguring and debilitating. Moreover, lymphoedema is connected with 
adverse psychological, emotional and socioeconomic sequelae which impair quality-of-life 
and well-being (McWayne & Heiney 2005, Person et al. 2009). 
Background  
Lymphoedema arises as a consequence of an inherited or acquired anomalous lymphatic 
system and affects people of all ages (Sneddon 2008, Ridner 2009). It is characterised by 
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enduring regional swelling of either the head / neck, upper and lower limbs and genitalia 
(Gary 2007) and categorised as either primary or secondary. Primary lymphoedema is 
associated with lymphatic malformation as a consequence of congenital or genetic factors, for 
example, Milroy’s Disease and Miege’s Disease (Ostergaard et al. 2011, Brouillard et al. 
2014). Secondary lymphoedema is connected with lymphatics damaged by trauma, burns, 
cardiac and venous diseases, surgery, cancer treatments and parasitic infections (Preston et al. 
2004, Wanchai et al. 2013). In developed countries cancer treatments are the leading cause of 
secondary lymphoedema (Rockson 2008, Saito et al. 2013, Brayton et al. 2014). 
Internationally, there is rising concern about the connection between chronic conditions, 
morbid obesity and lymphoedema (International Lymphoedema Framework 2012, Keast et al. 
2014).  
The incidence of lymphoedema varies in different illnesses (Park et al. 2008, Taghian 
et al. 2014). In terms of lymphoedema prevalence, Moffatt et al.’s (2003) frequently cited 
epidemiological study conducted in South-West London identified a prevalence rate of 1.33 
per 1000 patients. Prevalence estimates of cancer related lymphoedema have been reported in 
several small international studies, often using retrospective single centre cohort and cross 
sectional designs (for example, Ryan et al. 2003a, Penha et al. 2011, Deng et al. 2012). It has 
been argued that little is known about the prevalence of primary lymphoedema and secondary 
lymphoedema unrelated to cancer (Rockson & Rivera 2008, Gethin et al. 2011). Nonetheless, 
there seems to be universal agreement that prevalence rates are probably underestimated 
(Rockson & Rivera 2008).  
Lymphoedema may not be recognised or experienced as sufficiently problematical by 
some individuals to generate concern and thus report (Williams et al. 2005). Invariably 
however, failure to recognise, diagnose and report lymphoedema is a consequence of poor 
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awareness (Kwan et al. 2012, Keast et al. 2014, Civelek et al. 2015). For health professionals 
the situation may be compounded by the absence of a universally recognised and accepted 
definition of lymphoedema, unified measurement criteria and inadequate research attention 
(Paskett et al. 2007, Rockson & Rivera 2008, Brayton et al. 2014).  
Deficient knowledge and understanding of the importance of prevention, early 
recognition and effective management conjoined with inequitable access to specialist services 
is of international concern (Stout et al. 2012, Keast et al. 2014). Failure to recognise 
lymphoedema and initiate appropriate, effective therapeutic interventions generates adverse 
outcomes in terms of suffering, disability, disfigurement and distress (Keast et al. 2014). 
Indeed, the profound, lasting, adverse physical, psychological, psychosocial and economic 
impact of lymphoedema on individuals’ well-being, everyday functioning and health related 
quality-of-life is well documented (Ryan et al. 2003b, Williams et al. 2004, Franks et al. 
2006, Towers et al. 2008, Symvoulakis et al. 2010, Dunberger et al. 2013, Okajima et al. 
2013).  
Lymphoedema’s complex, enduring nature necessitates early detection, integrated, 
multiprofessional interventions and supported self-management. Accordingly the concept of 
locally accessible multiprofessional specialist lymphoedema services is gaining credence 
internationally (Park et al. 2008, Morgan et al. 2012). The Welsh Government has had 
devolved responsibility for health care and policy since 1999. The National Lymphoedema 
Service was founded in 2011 to provide local multiprofessional clinics across Wales. Eight 
clinics have been established. The following study was designed to explore people’s views 
and experiences of these clinics given that exploring experience is a first step in generating a 
new body of knowledge. By reporting findings from this study this paper aims to fill a gap in 
extant literature.  
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THE STUDY 
Aim 
The aim of this research was to explore and describe peoples’ views and experiences of the 
specialist lymphoedema clinics. Specifically we sought to address two research questions:  
1. What is it like to live with lymphoedema in terms of its effect on quality of life and 
well-being?  
2. In what ways has access to local lymphoedema clinics made a difference to their 
lives?  
Design 
A qualitative exploratory study using focus groups (Kreuger & Casey 2008) was designed. 
Focus groups, an established form of focused collective discussion on a defined topic, issue or 
experience are ideal for examining individuals’ experiences (Kitzinger, 1994, 2005). An 
expedient method of generating data from several people simultaneously, they are popular in 
nursing and health research (Reed & Payton 1997, McLafferty 2004). Skilled facilitation 
capitalises on participants’ interactions and generates rich data which may not be obtained 
through individual interviews (Webb & Kevern 2001, Ryan et al. 2015). For this research, 
focus groups would provide a platform for participants with an element of common 
experience to reflect, listen to and share experiences in company and enable natural talk to 
emerge and flow in a supportive environment.  
Participants  
Convenience sampling was used to recruit individuals attending eight local lymphoedema 
clinics in Wales who could share experiences of the clinic’s impact on their lives. We hoped 
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to recruit at least 48 participants. Access was granted by each clinic’s lead practitioner. 
Participants were recruited in 2013 by publicising the project in each clinic. Inclusion criteria 
were: adults living with lymphoedema; able to consent and proficient in the English language.  
Ethical considerations 
Approval was granted by the University and relevant Health Board research ethics 
committees. All participants gave written informed consent prior to the focus group. At the 
start of each focus group ground rules regarding confidentiality were established. It was 
emphasised that all participants must respect confidentiality and not share information 
discussed or identify individuals involved outside of the group. All participants were assured 
they could withdraw from the study at any time without this affecting their care.  None ended 
their participation or withdrew from the study.     
Data collection  
Focus group interviews (n=8) were conducted in every Welsh local lymphoedema clinic 
during July and August 2013. The decision to hold eight focus groups was pragmatic, 
influenced by timescales and the desire to cover all clinics in Wales. Each focus group was 
assigned a code, for example FGH. FG indicates the focus group whilst a letter indicates the 
clinic.  
RD, an experienced focus group researcher not known to participants, facilitated all 
focus groups. These lasted approximately one hour, were digitally recorded and discussion 
aided by a loose interview guide derived from the literature and expert advice (Table 1). This 
was adapted during data collection to incorporate emergent themes from preliminary analysis.  
Data analysis 
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Data were analysed using a qualitative content approach guided by the research aim and 
questions (Coffey & Atkinson 1996). Interviews were transcribed into Word© documents and 
identifying features removed. To ensure their accuracy transcripts were read whilst 
simultaneously listening to corresponding recordings. Two researchers read transcripts 
repeatedly to ensure familiarity and deep understanding of the data and facilitate dependable 
analysis. Independently the researchers manually coded transcripts. Consensus regarding 
codes was achieved during joint discursive review. To visually identify data with shared 
codes, data segments with a common code were colour highlighted (Coffey et al. 1996). 
Codes were abstracted into sub-categories, categories and broad overarching themes, 
scrutinised for similarity and duplication, discussed, refined and reduced until mutual 
agreement between the researchers was reached (Table 2).  
Rigour 
Rigour was enhanced by drawing on measures to achieve credibility, transferability, 
dependability and confirmability (Lincoln & Guba 1985). Collection of data from a 
heterogeneous group of participants in eight geographically and socio-economically diverse 
Welsh regions, meticulous transcription, checking of all interviews and rigorous data analysis 
by two researchers independently and collectively contributed to credibility. Detailed 
descriptions of experiences aided transferability whilst an audit trail of methodological 
decisions ensured dependability and confirmability. 
 
FINDINGS  
Fifty-nine people, 49 women and 10 men aged between 22–86 years participated in eight 
focus groups. Average focus group size was 7, range 3-11 (Table 3).   
Please insert Table 3 here  
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Twenty five participants (7 men, 18 women) reported cancer-related lymphoedema and 34 (3 
men, 31 women) reported non-cancer related lymphoedema (Figure 1).  
Data analysis identified three themes which captured participants’ experiences, namely: living 
with lymphoedema; diagnostic delays and the positive impact of local lymphoedema clinics.      
‘It is a battle’: Living with lymphoedema  
In all focus groups there was consensus regarding the profound, unremitting and interlinked 
physical and psychosocial impact of lymphoedema on participants’ lives. The magnitude of 
this is encapsulated in one participant’s use of combat metaphor:  
It is a battle: it has been a battle (….) [breast cancer] didn’t change my life this 
[lymphoedema] did. (FGB)  
Bulky, painful, heavy limbs, skin prone to uncontrollable weeping and enduring 
discomfort were articulated across all focus groups. Participants frequently drew attention to 
disrupted sleep and restricted physical functioning, particularly during warm weather. Several 
had experienced recurrent cellulitis precipitated by insect bites or minor trauma.  
There was agreement across focus groups that these problems placed substantial 
limitations on living a normal life. This was because engaging in everyday living activities 
was difficult:  
My legs just go double the size. You can just feel it and the tightness (….) I get 
pains then and cramp of the calves as well, so it is really hard work when you 
have a 6 year old. (FGH) 
Many participants had continued working. However, this could be challenging as 
lymphoedema induced functional limitations impacted on work performance and enforced 
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sickness absence. Despite employers’ support in terms of reasonable adjustments, some chose 
early retirement:  
The senior nurse took me off the ward and I was office based (….) I decided then 
I had had enough and I just retired (….) I feel really grieved. (FGB) 
The psychosocial effects of living with lymphoedema were considerable. Most 
participants had lived with lymphoedema for many years. Almost all spoke of adversely 
altered body-image, social isolation and emotional distress. 
The shattering impact of lymphoedema on body-image was marked. Concerns about a 
discredited body in terms of appearance and attractiveness were persistently reported across 
focus groups. Several women felt unable to wear fashionable clothing and footwear. For some 
this was due to an inability to find clothes and shoes which fitted. Nevertheless, many 
participants’ articulated that enlarged limbs, poor skin condition, compression bandages and 
garments generated a sense of unattractiveness, shame and an internal perception of external 
criticism. Consequently many expressed a felt need to cover up:  
People do look at your legs or arms and they might not be thinking ‘ah look at her 
over there’ but inside you think ‘I have got to cover that up’. (FGF) 
I would love to wear a short skirt. I do wear skirts but I do think I need to wear 
certain length skirts. (FGG) 
Negative self-image, restricted mobility and uncertainty associated with an 
unpredictable, disobedient body engendered a degree of social isolation. One participant with 
primary lower leg lymphoedema explained that prior to referral she not had left home for 
fourteen years. Others, whilst not housebound, had become unable to fully partake in social 
events and leisure activities, notably overseas travel and sport.  
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 I used to play golf a lot and it [lymphoedema] sort of got in the way. (FGB) 
I used to go running 3 nights a week (…) I can’t do that now. (FGE)   
Some had sought to maintain social contact through leisure activity in local peer support 
groups. Nevertheless, accessibility and availability challenges meant this was not always 
sustained.  
Emotional distress was prominent across all focus groups. Several participants 
articulated changes in emotional state: 
The depression can set right in and you feel like you are on your own. I don’t 
know if it is like it for you two?  
It was yes. [together] (FGF)  
We try not to be depressed but you can’t help it especially when you don’t really 
know what it is and no one is listening to you. (FGA) 
In addition some voiced exasperation with the lack of recognition of the psychological impact 
of lymphoedema and were resolute that something had to be done: 
There has got to be awareness of the psychological aspect of lymphoedema. 
People don’t realise how down and misunderstood you feel. (FGC)  
Nothing was done until about a year ago’: Delays in correct diagnosis  
In participants’ eyes, many health professionals had insufficient understanding of 
lymphoedema. There was consensus that this knowledge deficit had resulted in diagnostic 
delay and access to appropriate treatment and support.  
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Across focus groups diagnostic delay was the norm for participants with primary 
lymphoedema. Yet most participants treated for cancers reported diagnostic delays. Invariably 
delays were a consequence of insufficient awareness of lymphoedema and mistaken 
attribution. 
The majority of participants lamented health professionals’ limited awareness of 
lymphoedema:  
There seems (…..) almost total lack of awareness of lymphoedema (….) health 
professionals are not looking beyond the obvious. (FGC)  
Some participants with cancer related lymphoedema revealed they were unaware of its 
possibility as they had been inadequately informed:  
I asked [dermatologist] about lymphoedema and she said by this time [1 year post 
diagnosis] if you were going to get it you would have it already. (FGB)  
 [I] was told if you went gardening wear gloves to save getting any prickles 
because you would get lymphoedema. Well I don’t do gardening so I thought it 
won’t happen to me and I had such a shock when my arm started swelling. (FGD) 
A frequently reported view was that lymphoedema was not addressed in healthcare 
professionals’ education. Some participants’ believed health professionals’ were simply 
disinterested. It was suggested that public awareness of lymphoedema was limited too: 
You very rarely meet someone who knows what lymphoedema is, they 
automatically think cancer. (FGG)  
Many participants with primary lymphoedema described how they had been treated, 
often over many years, for swollen legs, fluid retention, weight gain and leg ulcers:  
15 
 
I was treated at my surgery by the practice nurse who used to put dressings on and 
different bits and pieces but it got worse. (FGH)  
I was told (…) ‘you are on your feet to much and here are some diuretics, take a 
couple of paracetamol and put your feet up’. (FGC)   
A correct diagnosis and access to appropriate treatment was often serendipitous: the 
outcome of chance encounters with different nurses or physiotherapists who knew about 
lymphoedema and expedited referral to specialist lymphoedema services:  
The district nurse I was going to for something else (…) saw my legs and she 
said, ‘My God we can do something about those, you have got lymphoedema’. 
(FGC)  
[Physiotherapist] said ‘I think the best place for you is (….) lymphoedema clinic’ 
(….). ‘You have lymphoedema, so I will refer you’. (FGB)  
Several participants revealed they learnt about lymphoedema through family, friends or 
their own research and requested specialist referral:  
I diagnosed it myself from a medical article (….) I went to see my GP and said ‘I 
think this is what I have got’. (FGC)  
However, before local clinics existed, accessing specialist services involved lengthy, 
costly journeys to specialist providers across the UK or Welsh hospices. While some were 
referred to regional Welsh cancer centres, access for individuals with primary lymphoedema 
was contingent on where they lived. One woman with primary lower limb lymphoedema 
explained:  
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(GP) referred me [to oncology centre]. He said ‘I don’t know if they will accept 
you because you are not in [names place]…. we didn’t hear anything. (FGF)    
Without specialist treatments individuals’ experienced substantial deterioration of their 
primary lymphoedema:  
I was refused treatment in [names two oncology centres] (….) I have got it 
[lymphoedema] now in both arms and legs. (FGE) 
 ‘It has changed my life’: The impact of the local specialist led lymphoedema clinics.  
There was agreement that referral to local specialist lymphoedema clinics was positive. Needs 
based care delivered in close proximity to participants’ homes by named specialist 
practitioners and irrespective of lymphoedema aetiology was highly valued. People had the 
correct treatment by the most appropriate professional, mostly at right time. Clinics 
engendered local networks of support and were motivating forces for participants to positively 
engage in self-management. Ultimately participants’ felt their quality-of-life was vastly 
improved. Nonetheless, concerns about services’ long-term sustainability were voiced.   
Even though initial appointments could take up to 26 weeks from referral local clinics 
were generally applauded across all focus groups. At one level the positive regard for clinics 
was related to geographical accessibility, enhanced in some areas through use of transportable 
healthcare units: local clinics were convenient, cost-effective, saved time and minimised 
interference with employment: 
 I find it very convenient, cost-effective as far as fuel is concerned. (FGH)   
17 
 
I haven’t missed a day [off work] since coming here which is brilliant (….) I 
have no problem getting here, or getting to work from here (…) and it is so easy 
to park.  (FGF)   
Accessibility was important when daily compression bandaging over three consecutive weeks 
was required. Moreover, many participants articulated that once assessed practitioners offered 
telephone advice and created spaces in busy schedules to see them if required: 
Last week both my legs were running with liquid into my shoes. I was in such a 
state I wanted to cut my legs off and I rang up at 9am on Friday morning and 
they said (….) there are only 2 of us on, come in and we will fit you in and they 
did. (FGD)  
Participants valued this needs based individualised approach. Continuity was deeply 
appreciated and participants frequently described staff as ‘fantastic’ and ‘wonderful’. Their 
specialist knowledge, expertise, flexibility, willingness to share information and attention to 
fine detail, a common example across focus groups being limb measurement, a new 
experience for many, was highly regarded. Applied expertise and continuity made significant 
positive differences in terms of participants’ reported outcomes and quality-of-life. One 
person, a trained dancer with primary lymphoedema explained:  
it [lymphoedema] nearly finished my career (….) the treatment has already made 
a difference to my life what they have done in the last few months here and I wish 
it had happened sooner (….) I have never seen my leg and ankle so small and I 
sometimes just stand and look at in the mirror because I can’t believe it and it just 
gives me a bit of hope. (FGG)  
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Some participants in one focus group however were profoundly dissatisfied with their 
clinic. While the named practitioner was described as ’marvellous’, some were discontented 
with the clinic’s organisation:  
 The service is terrible. It could be a good service but it is just getting 
appointments. I have got so frustrated trying to get appointments (FGB)   
For those in employment the prime concern was frequently cancelled appointments. Yet 
bureaucracy and a perceived disregard for individual’s treatment preferences were also 
mentioned.  
Many described how they were motivated to reciprocate by accommodating 
lymphoedema into their lives through engaging in self-management: meticulous hygiene, skin 
care, self-massage, protection from insect bites and trauma, wearing compression garments 
and taking regular exercise:  
Coming here, it encourages you to do all the simple lymph drainage (…) the fact 
that someone has actually worked on you makes you feel I have got to give 
something back. (FGG)      
Participants also spoke of seeking information and peer support through social media and the 
Lymphoedema Support Network:  
I met with people from across the UK through the lymphoedema support network 
and I got involved in the young person’s planning for lymphoedema (FGF) 
The ultimate aim of self-management was to prevent and reduce the risk of adverse 
complications: cellulitis, hospitalisation, exacerbation of lymphoedema and associated effects 
and maximise quality-of-life. Yet not all participants could independently self-manage their 
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lymphoedema. Some described difficulties in putting on and removing compression garments 
unaided. Invariably this was due to arthritis and when people lived alone this was particularly 
problematic: 
They did get me a pair of stockings which was brilliant because I have got arthritis 
and I couldn’t open them to put them on so it was a complete and utter waste of 
time (….) there was no one to help me and I did try. (FGE)  
Others required professional support, particularly with regard to infection prevention and 
prophylactic antibiotics. Nevertheless, several participants felt their concerns were not taken 
seriously and even trivialised by non-specialists:  
I rang the nurse at the surgery and I said to her ‘I’ve got these mosquito bites and I 
have got lymphoedema and I will need an antibiotic straight away.’ ‘What?’ she 
said, ‘for midge bites?’ and I said ‘No, because the midge bites could cause an 
infection’ and she said ‘I don’t think you need antibiotics’. (FGD)   
Participants were cognisant of increasing lymphoedema prevalence and potential 
associated future demands. Concern about long-term sustainability in a dynamic, fiscally 
bounded health care system was expressed as was unease about capacity to cope with 
demand:  
I don’t think it [the service] is adequate for all people who have got it 
[lymphoedema] (….) there is not enough staff. (FGE)    
Moreover, many participants, particularly those in rural areas were worried about what would 
happen in the event of long-term sickness, practitioners moving on and funding changes:  
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You get somebody who knows what they are doing and then they move on and 
then there is a dip in the service (…) I don’t want to see this service disintegrate. 
(FGA) 
DISCUSSION  
The All-Wales lymphoedema service is an exemplar which will be of interest to strategic 
managers and policy makers across the United Kingdom. This is because of the positive 
patient-reported outcomes illuminated in findings presented here.  Furthermore subsequent 
analysis of the Service’s economic impact, reported elsewhere, has indicated the potential for 
reductions in healthcare resource use (Humphreys & Fitzsimmons 2015).      
In this unique study participants’ voiced their experiences of living with lymphoedema 
and the influence of specialist local lymphoedema clinics on their lives. People’s experiences 
of living with lymphoedema have been previously considered (Williams et al. 2004, 
Meiklejohn et al. 2013). However, the predominant focus has been women with breast cancer 
related arm lymphoedema (Johansson et al. 2003, Fu & Rosedale 2009). Service provision for 
this population may be better than for others living with lymphoedema. Indeed, Hodgson et 
al.’s (2011) Canadian study identified restricted access to treatment for many with non-cancer 
related lymphoedema.  
For the first time our study reveals that access to specialist localised clinics made a 
meaningful difference to peoples’ lymphoedema and thus their lives, engendered positive 
outcomes and improved adherence to lymphoedema self-management. The latter is a 
particularly important finding given international policies emphasising individuals’ active 
engagement in managing chronic illness (Department of Health 2005, Welsh Assembly 
Government 2007, Health Council of Canada 2012). Yet, our data also revealed that some 
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participants did not have the physical capacity to self-manage their lymphoedema and had no 
access to alternate support.  
The finding that lymphoedema related physical restraints and functional losses were 
considerable, generated immense challenges and at times placed overwhelming restrictions on 
participants’ everyday activities reflects findings from earlier research (Lam et al. 2006, 
Bogan et al. 2007, Fu & Rosedale 2009, Vassard et al. 2010). What this study adds is a 
glimpse into the endless hard work of living with lymphoedema, an aspect articulated in focus 
groups through combat metaphor. Lakoff & Johnson (1980) contended that metaphor aids the 
definition and expression of subjective reality. In our study participants’ use of metaphor 
illuminated the unremitting effort required to incorporate lymphoedema into their everyday 
lives, the resultant lifework challenges and disruptions they encountered and sought to 
overcome. It is of little surprise that inextricably entwined with physical and functional 
restraints and resultant demand was enduring psychosocial suffering.  
Data revealed how lymphoedema adversely permeated social networks, activities and 
employment. This resonates with findings from previous studies (Bogan et al. 2007, Fu & 
Rosedale 2009, Ridner et al. 2012). However, the vocabulary of discredited, disobedient 
bodies, articulated embarrassment, shame and marginalisation conjoined with the propensity 
for bodily concealment and self-isolation indicated entrenched felt stigma, the internal 
perception of shame associated with having a visible, potentially discrediting condition and 
fear of others’ reactions (Scambler & Hopkins 1986, Lebel et al. 2013). Few participants 
indicated that they had directly experienced lymphoedema related enacted stigma: prejudicial, 
distressing insults about their shape, size and skin condition. However, self-imposed 
avoidance and bodily concealment are protective coping strategies which may signal 
anticipated and feared enacted stigma. Ultimately the confluence of disrupted self-concept 
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and mediating strategies may contribute to the burden of lymphoedema by engendering 
deleterious psychosocial and behavioural outcomes.  
The complex amalgamation and interplay of physical and functional restraints, 
disrupted lifestyles and psychosocial suffering signals the need for and importance of holistic 
supportive interventions. Regrettably our data revealed continued shortcomings in 
lymphoedema care and support in general hospital and community settings. In part, this seems 
to relate to healthcare professionals’ insufficient lymphoedema knowledge and understanding 
and reflects findings from earlier studies (Williams et al. 2004, Lam et al. 2006, Bogan et al. 
2007, Sneddon 2008, Vassard et al. 2010, Davies 2012, Barlow et al. 2014). However, the 
extent to which participants with cancer related lymphoedema struggled to access diagnosis 
and appropriate treatment was an unexpected finding. Lymphoedema prevalence is projected 
to increase. This will impact on demand for care. Accordingly investment in accessible 
lymphoedema education for non-specialist health professionals and updating for specialists is 
warranted to raise awareness, improve prevention, management and psychosocial support 
strategies, reduce diagnostic delay and ultimately enhance affected individuals’ quality-of-life 
and sense of well-being. Yet there is also a pressing need to raise the profile of lymphoedema 
amongst policy makers. 
The data showed that specialist lymphoedema clinics were highly regarded. In part 
this was because they were locally accessible. Innovative mobile clinics were valued for ease 
of access which generated less disruption to participants’ lives. Wang et al. (2014) highlighted 
accessibility challenges experienced by rural Australians with lymphoedema and the impact 
of foregoing treatment and commuting long distances for treatment on quality-of-life. These 
sophisticated healthcare units are used internationally to reach out to under-served rural and 
urban populations in developed and developing worlds (Carmack 2010, Guruge et al. 2010). 
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Further empirical investigation of transportable healthcare units in terms of populations 
served, health outcomes and cost-effectiveness is required (Brooks et al. 2013, Browder et al. 
2015). Nonetheless, their potential in lymphoedema service delivery, particularly in rural 
areas, should not be dismissed.  
Specialist clinics were acceptable because participants experienced apposite, holistic 
patient-centred care which was not discontinuous. Essentially individuals felt both cared for 
and about. It is likely that this is because their needs were expertly met in a supportive 
relational space, an approach which connects with findings from early investigations into 
patients’ perspectives of good care (Attree 2001). Importantly, our data revealed that the 
positive experience motivated participants toward sustained lymphoedema self-management 
and lifestyle changes. This finding contrasts with those from recent research indicating 
inadequate adherence to lymphoedema self-management, particularly wearing compression 
garments and self-massage amongst women with breast cancer related lymphoedema (Brown 
et al. 2014, Alcorso et al. 2016).  
Lymphoedema self-management can be time-consuming and burdensome, particularly 
in the absence of additional support. Moreover, compression garments may generate 
discomfort and serve as visible reminders of the condition and, in cancer related 
lymphoedema, the disease and its treatment. It is entirely possible that these factors may 
influence decisions whether to wear garments or not.  Nevertheless, enduring lymphoedema 
self-management is important to manage regional swelling, reduce the risk of complications 
and potential psychosocial ramifications and possibly healthcare use and thus costs.  
The findings signal the need for further investigation of the barriers and facilitators of 
supported self-management in lymphoedema. They also have important implications for 
practitioners, strategic managers responsible for service development and policy makers 
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globally, not least because engagement in supported self-management may help temper 
escalating demands on scarce resources and thus save costs (Wanless 2004). However, this is 
by no means certain as influential commentators and researchers have observed (Greenhalgh 
2009, Panagioti et al. 2014).     
Limitations 
The study is not without limitations. Whilst the sample is small it is in accord with the study’s 
aims and in terms of exploratory qualitative research adequate. Yet the findings reflect 
experiences of a heterogeneous sample of self-selecting participants in one region of the UK. 
It is probable individuals volunteered to participate because they wanted to share their stories 
about living with lymphoedema and how being able to access local clinics changed their lives. 
In terms of policy and practice important lessons can be learnt from the experiences of 
individuals living in Wales. 
CONCLUSIONS  
Local specialist lymphoedema clinics can make a positive difference to the lives of people 
living with lymphoedema by improving accessibility, expert lymphoedema management and 
augmenting patient outcomes, for example, knowledge and adherence to lymphoedema self-
management. It is plausible that these improvements may not only enhance individuals’ 
quality of life and sense of wellbeing but also be cost-effective in the longer term by for 
example reducing healthcare costs due to complications such as cellulitis or deterioration in 
lymphoedema leading to adverse patient outcomes and socioeconomic costs. Nevertheless the 
magnitude of effect is uncertain and further empirical investigation, including economic 
evaluation of specialist clinics is required to capitalise on the findings reported here.     
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